Effect of delays on prognosis in patients with non-small cell lung cancer.

Gunnar Mýrdal, Mats Lambe, Gunnar Hillerdal, +3

PubMed

Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Christer Sederholm, Gunnar Hillerdal, Kristina Lamberg, +4

Journal of Clinical Oncology

CD99 is a novel prognostic stromal marker in non‐small cell lung cancer

Karolina Edlund, Cecilia Lindskog, Akira Saito, +17

International Journal of Cancer

ImmunologyPathologyNsclc SamplesCancer BiologyTumor Biology +16

Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients

Daniel Brattström, Michael Bergqvist, Patrik Hesselius, +5

Lung Cancer

Tumor BiologyPoorer SurvivalMedicinePathologyLarger Primary Tumours +8

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

Andrea Koch, Bengt Bergman, Erik Holmberg, +7

European Journal of Cancer

MedicinePathologyBronchial NeoplasmCancer TreatmentOncology +5

Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.

O Nettelbladt, Anders Sundin, Sven-Olof Valind, +4

PubMed

Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer

Patrick Micke, Karolina Edlund, Lars Holmberg, +14

Journal of Thoracic Oncology

OncologySomatic VariantHistologic SubgroupsTumor HeterogeneityMedicine +9

Regional differences in treatment and outcome in non-small cell lung cancer: A population-based study (Sweden)

Gunnar Mýrdal, Kristina Lamberg, Mats Lambe, +3

Lung Cancer

Population-based StudyMedicineCancer ManagementEpidemiology Of CancerRegional Differences +6

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Oliver Illini, Maximilian J. Hochmair, Hannah Fabikan, +30

Therapeutic Advances in Medical Oncology

Spatial immunophenotyping of the tumour microenvironment in non–small cell lung cancer

Max Backman, Carina Strell, Amanda Lindberg, +15

European Journal of Cancer